Guru Ownership Trend
Guru Analysis for Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $62.88 M.
Top institutional holders include Catherine Wood and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $33.59 M net outflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Steven Cohen reduced exposure by 86.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Nurix Therapeutics, Inc. (NRIX)
Major holders include Catherine Wood ($26.68 M), Steven Cohen ($6.96 M), Ken Fisher ($5.96 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.69 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $33.59 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited NRIX. The total reported sell value was $43.48 M.
Yes, 3 managers opened new positions in NRIX, and 1 increased their existing holdings. The total reported buy value was $9.89 M.